Back to top
Read MoreHide Full Article

Brian Bolan, the aggressive growth stock strategist at Zacks Investment Research reviews two stocks that are both Zacks Rank #1 (Strong Buy) that also have growth style scores of “A.”  This week Brian highlights PetMed Express (PETS - Free Report) and discusses the recent “short and distort” style report that was floated about the company a few weeks ago.  Brian states that his experiences in buying medication for his pet Buckeye were the exact opposite of what the company was being accused of.  Brian believes the stock is not a dog and will run higher.  Crox (CROX - Free Report) is the next stock that is profiled and Brian speaks to higher earnings estimates.  Terry notes that the shoes must be worn by more people than just chef’s – and Brian speaks to more types of shoes than the original being sold.

One Simple Trading Idea

Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.

This proven stock-picking system is grounded on a single big idea that can be fortune shaping and life changing. You can apply it to your portfolio starting today.

Learn more >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


PetMed Express, Inc. (PETS) - free report >>

Crocs, Inc. (CROX) - free report >>


More from Zacks Video Blog

You May Like